Clearstead Advisors, LLC

SEC CIK: 0000842775
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

PXMD holding history

Kuvatris Therapeutics, Inc. in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PXMD overview All 13F holders of PXMD Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2023

Holdings of PXMD by Clearstead Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−1−100.0%	Sold out	Holders
Q1 2024	1	$1	<0.1%	−2,243−100.0%	Reduced	Holders
Q4 2023	2,244	$1.70K	<0.1%	−35,912−94.1%	Reduced	Holders
Q3 2023	38,156	$10.9K	<0.1%	+38,156	New	Holders